ARTICLE | Company News
Canada approves Vitaros for ED
November 16, 2010 1:14 AM UTC
Health Canada approved Vitaros from Apricus Biosciences Inc. (NASDAQ:APRI) for erectile dysfunction. The topical prostaglandin E1 (PGE1) cream is formulated with Apricus' NexACT transdermal delivery t...